Work

New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti‐DNA

FWCI: 0.843
Cites: 56
Cited by: 48
Related to: 10